Toll-like Receptor 2 Ligands Regulate Monocyte Fcγ Receptor Expression and Function
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Toll-like Receptor 2 Ligands Regulate Monocyte Fcγ Receptor Expression and Function
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 288, Issue 17, Pages 12345-12352
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2013-03-16
DOI
10.1074/jbc.m113.449983
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MF59 and Pam3CSK4 Boost Adaptive Responses to Influenza Subunit Vaccine through an IFN Type I-Independent Mechanism of Action
- (2012) E. Caproni et al. JOURNAL OF IMMUNOLOGY
- 2ndPEGS Annual Symposium on Antibodies for Cancer Therapy
- (2012) Mitchell Ho et al. mAbs
- MiR-155 Induction by Microbes/Microbial Ligands Requires NF-κB-Dependent de novo Protein Synthesis
- (2012) Thomas J. Cremer et al. Frontiers in Cellular and Infection Microbiology
- The Role of TLR2 in Infection and Immunity
- (2012) Laura Oliveira-Nascimento et al. Frontiers in Immunology
- Microbial Sensing by Toll Receptors
- (2011) Stanislava Chtarbanova et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- TLR2 Ligand Induces Protection against Cerebral Ischemia/Reperfusion Injury via Activation of Phosphoinositide 3-Kinase/Akt Signaling
- (2011) C. Lu et al. JOURNAL OF IMMUNOLOGY
- Toll-Like Receptor 2 Induced Angiogenesis and Invasion Is Mediated through the Tie2 Signalling Pathway in Rheumatoid Arthritis
- (2011) Tajvur Saber et al. PLoS One
- TLR2 ligands attenuate cardiac dysfunction in polymicrobial sepsis via a phosphoinositide 3-kinase-dependent mechanism
- (2010) Tuanzhu Ha et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Reciprocal Regulation of Activating and Inhibitory Fc Receptors by TLR7/8 Activation: Implications for Tumor Immunotherapy
- (2010) J. P. Butchar et al. CLINICAL CANCER RESEARCH
- TLR2 Agonists Enhance CD8+Foxp3+ Regulatory T Cells and Suppress Th2 Immune Responses during Allergen Immunotherapy
- (2010) Y.-G. Tsai et al. JOURNAL OF IMMUNOLOGY
- Targeting Toll-like receptors: emerging therapeutics?
- (2010) Elizabeth J. Hennessy et al. NATURE REVIEWS DRUG DISCOVERY
- Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein are targeted by miR-155 in B cells of E -MiR-155 transgenic mice
- (2009) S. Costinean et al. BLOOD
- Recognition of Lipopeptide Patterns by Toll-like Receptor 2-Toll-like Receptor 6 Heterodimer
- (2009) Jin Young Kang et al. IMMUNITY
- Monoclonal antibodies for cancer immunotherapy
- (2009) Louis M Weiner et al. LANCET
- Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer
- (2009) L. A. J. O'Neill et al. PHARMACOLOGICAL REVIEWS
- MiR-155 Induction by F. novicida but Not the Virulent F. tularensis Results in SHIP Down-Regulation and Enhanced Pro-Inflammatory Cytokine Response
- (2009) Thomas J. Cremer et al. PLoS One
- Inositol phosphatase SHIP1 is a primary target of miR-155
- (2009) R. M. O'Connell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Microarray Analysis of Human Monocytes Infected with Francisella tularensis Identifies New Targets of Host Response Subversion
- (2008) Jonathan P. Butchar et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started